Tim Karl
Barker Street
Sydney, NSW, Australia
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 94 publications
Inflammation-associated alterations in mGluR transcript expression in the human nucleus accumbens independent of schizophrenia diagnosis.
Journal: Schizophrenia research
Published: March 18, 2026
Effects of Chronic 100 mg/kg Cannabidiol Treatment in Male Double Transgenic APPSwe/PS1∆E9 Mice.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 12, 2026
ALS-FTD-linked CCNFS621G drives increased hippocampal astrocyte ramification and mitochondrial dysfunction and impairs motor neuron excitability.
Journal: Journal of neuroinflammation
Published: January 08, 2026
Genetic risk for schizophrenia modulates WIN 55,212-2 reward: Evidence from a heterozygous transmembrane domain neuregulin 1 mutant mouse model.
Journal: Psychopharmacology
Published: December 18, 2025
Cannabidiol (CBD) does not reduce cocaine reward or self-administration in a mouse model of schizophrenia genetic susceptibility.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: November 03, 2025
NF-κB pathway gene expression is elevated in the midbrain of people with high-inflammation schizophrenia.
Journal: Brain, behavior, and immunity
Published: October 09, 2025
Persistent morphine memory during abstinence in female, but not male, metabotropic glutamate 5 receptor knockout mice.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: September 14, 2025
Combining cannabidiol and delta-9-tetrahydrocannabinol at a 50:3 ratio - a new therapeutic strategy for APPSwe/PS1ΔE9 transgenic mice?
Journal: Neurobiology of aging
Published: September 02, 2025
Cannabidiol Modulates Brain Copper Homeostasis in Wild-Type-Like But Not Alzheimer's Disease Transgenic Female Mice: Implications for Neuroprotective Therapy.
Journal: Molecular neurobiology
Published: May 22, 2025
Sex-dependent Schizophrenia and Drug Reward Behavioral Phenotypes in Metabotropic Glutamate 5 Receptor Heterozygous and Homozygous Mice.
Journal: Schizophrenia bulletin
Published: February 17, 2025
Combination treatment with medium dose THC and CBD had no therapeutic effect in a transgenic mouse model for Alzheimer's disease but affected other domains including anxiety-related behaviours and object recognition memory.
Journal: Pharmacology, biochemistry, and behavior
Published: February 17, 2025
Knock-out of Tpm4.2/Actin Filaments Alters Neuronal Signaling, Neurite Outgrowth, and Behavioral Phenotypes in Mice.
Journal: Molecular neurobiology
Published: January 20, 2025
Last Updated: 09/26/2026